Preeclampsia (PE) is a condition that affects women during pregnancy. It is a leading cause of maternal and infant death worldwide and is typically detected in the second trimester or later. Predicting PE at an early stage is one of the most important goals of maternal-fetal medicine. Thus, there is an unmet need for accurate early detection of preeclampsia, ideally at the point-of-care. In a pilot study, microRNA-20a (miR-20a) showed an upregulation in the blood samples of the first trimester of preeclamptic pregnancies when compared to healthy mothers. In this research, a dual capture probe sandwich assay, sensitive to miR-20a, that used surface-enhanced Raman scattering (SERS)-active gold nanoparticles for the signal transduction was developed. The assay was translated to a lateral flow paper fluidic device, for potential low cost and ease of use in low-resource settings. Each paper layer has different pore sizes and features an array of buffers that store nanoparticle conjugates, guide flow, and reduce non-specific binding. Using a handheld Raman reader with a 638 nm excitation laser, reliable SERS detection of miR-20a was shown with resolutions down to 1 nM. Colorimetric detection of these concentrations using the RGB pixels from scanning the test line is also depicted, showing multi-modal detection to potentially enhance specificity for this early epigenetic biomarker.
|